The global cancer cachexia therapeutics market demonstrates significant growth, driven by the growing prevalence of cancer worldwide and a burgeoning demand for effective treatment options. Cachexia, a debilitating syndrome characterized by unintentional weight loss and muscle wasting, affects a considerable proportion of cancer patients, considera